A man in Johannesburg shared a Senior Java Developer’s payslip, showing a basic salary of a substantial amount The developer, who had seven years of experience, had a salary after deductions that ...
Hosted on MSN

Bro is 200IQ

Elon Musk warns a new social network where AI agents talk to one another is the beginning of 'the singularity' Canada has issued a travel advisory for Cuba. Here's what you need to know | Hanomansing ...
A tech founder from San Francisco was detained and jailed in Davos after he accidentally left a device authorities thought resembled a bomb at a luxury hotel hosting the World Economic Forum.
Engineers in Silicon Valley have been raving about Anthropic’s AI coding tool, Claude Code, for months. But recently, the buzz feels as if it’s reached a fever pitch. Earlier this week, I sat down ...
Over the holidays, Alex Lieberman had an idea: What if he could create Spotify “Wrapped” for his text messages? Without writing a single line of code, Lieberman, a co-founder of the media outlet ...
On Monday, Anthropic announced a new tool called Cowork, designed as a more accessible version of Claude Code. Built into the Claude Desktop app, the new tool lets users designate a specific folder ...
When the creator of the world's most advanced coding agent speaks, Silicon Valley doesn't just listen — it takes notes. "If you're not reading the Claude Code best practices straight from its creator, ...
Hoyoverse just wrapped up the Genshin Impact version "Luna 4" (or 6.3, as some others would liek to call it) preview livestream, showing off all sorts of details about the upcoming patch. Most ...
Sam Altman’s decision to declare a “code red” at OpenAI earlier this month may have caught the industry’s attention, but it wasn’t a first for the artificial intelligence company. The San ...
The items were taken in the late 19th century from what was then called the Dutch East Indies. Indonesia had been trying to get them back for decades. By Nina Siegal Reporting from Amsterdam The ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...